Advertisement

Archives of Pharmacal Research

, Volume 40, Issue 11, pp 1328–1335 | Cite as

Mollugin enhances the osteogenic action of BMP-2 via the p38–Smad signaling pathway

Research Article
  • 194 Downloads

Abstract

Bone morphogenetic protein 2 (BMP-2) has been used clinically to encourage bone regeneration; although, there can be major side effects with larger doses. Therefore, there is a need to identify new small molecules to potentiate the osteogenic action of BMP-2. In this study, we investigated the effect of mollugin on bone formation in murine bi-potential mesenchymal progenitor C2C12 cells by combination with BMP-2. We found mollugin could enhance the BMP-2-mediated osteoblast differentiation of C2C12 cells. This was accompanied by the induction of other osteogenic BMPs. We also found the enhancing potential of mollugin may involve activation of the p38–Smad1/5/8 signaling axis. Furthermore, mollugin promoted skeletal development in zebrafish. The combination of BMP-2 with small molecules, including mollugin, could minimize its clinical limitations, and these molecules might lead to the development of effective stem cell stimulants for bone regeneration and fracture healing.

Keywords

Mollugin BMP-2 p38 Smad Osteoblast Bone formation 

Notes

Acknowledgements

This work was supported by a project Grant (KK1703-F02) from the Korea Research Institute of Chemical Technology.

Compliance with ethical standards

Conflict of interest

The authors have declared no conflict of interest.

References

  1. Alt V, Donell ST, Chhabra A, Bentley A, Eicher A, Schnettler R (2009) A health economic analysis of the use of rhBMP-2 in Gustilo-Anderson grade III open tibial fractures for the UK, Germany, and France. Injury 40:1269–1275CrossRefPubMedGoogle Scholar
  2. Baek JM, Kim JY, Jung Y, Moon SH, Choi MK, Kim SH, Lee MS, Kim I, Oh J (2015) Mollugin from Rubea cordifolia suppresses receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorbing activity in vitro and prevents lipopolysaccharide-induced bone loss in vivo. Phytomedicine 22:27–35CrossRefPubMedGoogle Scholar
  3. Benglis D, Wang MY, Levi AD (2008) A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery. Neurosurgery 62:ONS423–ONS431PubMedGoogle Scholar
  4. Cao Y, Wang C, Zhang X, Xing G, Lu K, Gu Y, He F, Zhang L (2014) Selective small molecule compounds increase BMP-2 responsiveness by inhibiting Smurf1-mediated Smad1/5 degradation. Sci Rep 14:4965Google Scholar
  5. Chen D, Harris MA, Rossini G, Dunstan CR, Dallas SL, Feng JQ, Mundy GR, Harris SE (1997) Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts. Calcif Tissue Int 60:283–290CrossRefPubMedGoogle Scholar
  6. Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, Szatkowski JP, Park JY, He TC (2003) Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 8:1544–1552CrossRefGoogle Scholar
  7. Choi Y, Nam TG (2012) Chemical biology in stem cell research. Arch Pharm Res 35:281–297CrossRefPubMedGoogle Scholar
  8. Do MT, Hwang YP, Kim HG, Na M, Jeong HG (2013) Mollugin inhibits proliferation and induces apoptosis by suppressing fatty acid synthase in HER2-overexpressing cancer cells. J Cell Physiol 228:1087–1097CrossRefPubMedGoogle Scholar
  9. Du SJ, Frenkel V, Kindschi G, Zohar Y (2001) Visualizing normal and defective bone development in zebrafish embryos using the fluorescent chromophore calcein. Dev Biol 238:239–246CrossRefPubMedGoogle Scholar
  10. Fan J, Guo M, Im CS, Pi-Anfruns J, Cui ZK, Kim S, Wu B, Aghaloo T, Lee M (2016) Enhanced mandibular bone repair by combined treatment of bone morphogenetic protein 2 (BMP-2) and small molecule phenamil. Tissue Eng Part A 22:195–207CrossRefGoogle Scholar
  11. Fleming A, Sato M, Goldsmith P (2005) High-throughput in vivo screening for bone anabolic compounds with zebrafish. J Biomol Screen 10:823–831CrossRefPubMedGoogle Scholar
  12. Gallea S, Lallemand F, Atfi A, Rawadi G, Ramez V, Spinella-Jaegle S, Kawai S, Faucheu C, Huet L, Baron R, Roman-Roman S (2001) Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone 28:491–498CrossRefPubMedGoogle Scholar
  13. Gitelman SE, Kirk M, Ye JQ, Filvaroff EH, Kahn AJ, Derynck R (1995) Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells. Cell Growth Differ 6:827–836PubMedGoogle Scholar
  14. Ho LK, Don MJ, Chen HC, Yeh SF, Chen JM (1996) Inhibition of hepatitis B surface antigen secretion on human hepatoma cells. Components from Rubia cordifolia. J Nat Prod 59:330–333CrossRefPubMedGoogle Scholar
  15. Hong HS, Kim DY, Yoon KJ, Son Y (2011) A new paradigm for stem cell therapy: substance-P as a stem cell-stimulating agent. Arch Pharm Res 34:2003–2006CrossRefPubMedGoogle Scholar
  16. James AW, LaChaud G, Shen J, Asatrian G, Nguyen V, Zhang X, Ting K, Soo C (2016) A review of the clinical side effects of bone morphogenetic protein-2. Tissue Eng Part B 22:284–297CrossRefGoogle Scholar
  17. Jeong GS, Lee DS, Kim DC, Jahng Y, Son JK, Lee SH, Kim YC (2011) Neuroprotective and anti-inflammatory effects of mollugin via up-regulation of heme oxygenase-1 in mouse hippocampal and microglial cells. Eur J Pharmacol 654:226–234CrossRefPubMedGoogle Scholar
  18. Jun do Y, Han CR, Choi MS, Bae MA, Woo MH, Kim YH (2011) Effect of mollugin on apoptosis and adipogenesis of 3T3-L1 preadipocytes. Phytother Res 25:724–731CrossRefPubMedGoogle Scholar
  19. Kawai M, Bessho K, Maruyama H, Miyazaki J, Yamamoto T (2006) Simultaneous gene transfer of bone morphogenetic protein (BMP) -2 and BMP-7 by in vivo electroporation induces rapid bone formation and BMP-4 expression. BMC Musculoskelet Disord 7:62CrossRefPubMedPubMedCentralGoogle Scholar
  20. Kawasaki Y, Goda Y, Yoshihira K (1992) The mutagenic constituents of Rubia tinctorum. Chem Pharm Bull (Tokyo) 40:1504–1509CrossRefPubMedGoogle Scholar
  21. Kim HJ, Kim SH (2010) Tanshinone IIA enhances BMP-2-stimulated commitment of C2C12 cells into osteoblasts via p38 activation. Amino Acids 39:1217–1226CrossRefPubMedGoogle Scholar
  22. Kim SN, Kim MH, Min YK, Kim SH (2008) Licochalcone A inhibits the formation and bone resorptive activity of osteoclasts. Cell Biol Int 32:1064–1072CrossRefPubMedGoogle Scholar
  23. Kim KJ, Lee JS, Kwak MK, Choi HG, Yong CS, Kim JA, Lee YR, Lyoo WS, Park YJ (2009) Anti-inflammatory action of mollugin and its synthetic derivatives in HT-29 human colonic epithelial cells is mediated through inhibition of NF-κB activation. Eur J Pharmacol 622:52–57CrossRefPubMedGoogle Scholar
  24. Kim SN, Bae SJ, Kwak HB, Min YK, Jung SH, Kim CH, Kim SH (2012) In vitro and in vivo osteogenic activity of licochalcone A. Amino Acids 42:1455–1465CrossRefPubMedGoogle Scholar
  25. Kwak HB, Yang D, Ha H, Lee JH, Kim HN, Woo ER, Lee S, Kim HH, Lee ZH (2006) Tanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1. Exp Mol Med 38:256–264CrossRefPubMedGoogle Scholar
  26. Lee KS, Hong SH, Bae SC (2002) Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene 21:7156–7163CrossRefPubMedGoogle Scholar
  27. Lee YR, Wang X, Kim YM, Shim JJ, Kim BN, Han DH (2007) Concise synthesis of biologically interesting mollugins and its analogues. Bull Korean Chem Soc 28:1735–1738CrossRefGoogle Scholar
  28. Lee YM, Auh QS, Lee DW, Kim JY, Jung HJ, Lee SH, Kim EC (2013) Involvement of Nrf2-mediated upregulation of heme oxygenase-1 in mollugin-induced growth inhibition and apoptosis in human oral cancer cells. Biomed Res Int 2013:210604PubMedPubMedCentralGoogle Scholar
  29. Li JZ, Li H, Sasaki T, Holman D, Beres B, Dumont RJ, Pittman DD, Hankins GR, Helm GA (2003) Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Ther 10:1735–1743CrossRefPubMedGoogle Scholar
  30. Li N, Felber K, Elks P, Croucher P, Roehl HH (2009) Tracking gene expression during zebrafish osteoblast differentiation. Dev Dyn 238:459–466CrossRefPubMedGoogle Scholar
  31. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25:402–408CrossRefPubMedGoogle Scholar
  32. Lrad TW, Einhorn TA (2009) Bone morphogenetic proteins in orthopaedic surgery. Cytokine Growth Factor Rev 20:481–488CrossRefGoogle Scholar
  33. McKay WF, Peckham SM, Badura JM (2007) A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE bone graft). Int Orthop 31:729–734CrossRefPubMedPubMedCentralGoogle Scholar
  34. Mondal S, Bandyopadhyay S, Ghosh MK, Mukhopadhyay S, Roy S, Mandal C (2012) Natural products: promising resources for cancer drug discovery. Anticancer Agents Med Chem 12:49–75CrossRefPubMedGoogle Scholar
  35. Moon SH, Choi SW, Park SJ, Ryu SY, Hwang KS, Kim CH, Kim SH (2015) In vitro and in vivo bone-forming activity of Saururus chinensis extract. Phytother Res 7:1073–1080CrossRefGoogle Scholar
  36. Nishikawa R, Anada T, Ishiko-Uzuka R, Suzuki O (2014) Osteoblastic differentiation of stromal ST-2 cells from octacalcium phosphate exposure via p38 signaling pathway. Dent Mater J 33:242–251CrossRefPubMedGoogle Scholar
  37. Nishimura R, Kato Y, Chen D, Harris SE, Mundy GR, Yoneda T (1998) Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J Biol Chem 273:1872–1879CrossRefPubMedGoogle Scholar
  38. Nöth U, Tuli R, Seghatoleslami R, Howard M, Shah A, Hall DJ, Hickok NJ, Tuan RS (2003) Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Exp Cell Res 291:201–211CrossRefPubMedGoogle Scholar
  39. Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132:365–386PubMedGoogle Scholar
  40. Suzuki A, Guicheux J, Palmer G, Miura Y, Oiso Y, Bonjour JP, Caverzasio J (2002) Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation. Bone 30:91–98CrossRefPubMedGoogle Scholar
  41. Weaver CM, Alekel DL, Ward WE, Ronis MJ (2012) Flavonoid intake and bone health. J Nutr Gerontol Geriatr 31:239–253CrossRefPubMedPubMedCentralGoogle Scholar
  42. Yamachika E, Tsujigiwa H, Shirasu N, Ueno T, Sakata Y, Fukunaga J, Mizukawa N, Yamada M, Sugahara T (2009) Immobilized recombinant human bone morphogenetic protein-2 enhances the phosphorylation of receptor-activated Smads. J Biomed Mater Res A 88:599–607CrossRefPubMedGoogle Scholar
  43. Yamaguchi A, Ishizuya T, Kintou N, Wada Y, Katagiri T, Wozney JM, Rosen V, Yoshiki S (1996) Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun 220:366–371CrossRefPubMedGoogle Scholar
  44. Yeh LC, Tsai AD, Lee JC (2002) Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12. J Cell Biochem 87:292–304CrossRefPubMedGoogle Scholar
  45. Zhu ZG, Jin H, Yu PJ, Tian YX, Zhang JJ, Wu SG (2013) Mollugin inhibits the inflammatory response in lipopolysaccharide-stimulated RAW264.7 macrophages by blocking the Janus kinase-signal transducers and activators of transcription signaling pathway. Biol Pharm Bull 36:399–406CrossRefPubMedGoogle Scholar

Copyright information

© The Pharmaceutical Society of Korea 2017

Authors and Affiliations

  1. 1.Bio & Drug Discovery Division, Center for Drug Discovery TechnologyKorea Research Institute of Chemical TechnologyDaejeonRepublic of Korea
  2. 2.Department of BiologyChungnam National UniversityDaejeonRepublic of Korea
  3. 3.Department of Strategy and PlanningKorea Institute of Science and Technology InformationSeoulRepublic of Korea
  4. 4.College of Pharmacy and Yonsei Institute of Pharmaceutical SciencesYonsei UniversityIncheonRepublic of Korea

Personalised recommendations